Kong, X.D.# and Tian C., De novo discovery of bicycles. Nat. Chem. Biol. 2025, 21, 29–31.

Han, Y., Luo, Y., Ma, B.D., Li J.#, Xu, J.H.#, and Kong, X.D.#, Structural insights of a cis-epoxysuccinate hydrolase facilitate the development of robust biocatalysts for the production of l-(+)-tartrate. Biochem., 2024, 63, 12, 1578–1587.

He, R.N., Zhang, M.J., Dai B.# and Kong, X.D.#, Selection of peptide−bismuth bicycles using phage display. ACS Chem. Biol. 2024, 19, 5, 1040–1044.

Zhu, X.X., Zheng, W.Q., Xia, Z.W., Chen, X.R., Jin, T., Ding, X.W., Chen, F.F., Chen, Q., Xu, J.H., Kong, X.D.#, and Zheng, G.W.#, Evolutionary insights into the stereoselectivity of imine reductases based on ancestral sequence reconstruction. Nat. Commun., 2024, 15: 10330.

Sun, C., Ma, B.-D., Li, G., Tian, W., Yang, L., Peng, H., Lin, Z., Deng, Z., Kong, X.D.#, and Qu, X.#, Engineering the substrate specificity of a P450 dimerase enables the collective biosynthesis of heterodimeric tryptophan-containing diketopiperazines. Angew. Chem. Int. Ed., 2023, 62: e202304994.

Kong X.D., Heinis C. Towards the development of orally available peptide therapeutics. Chimia, 2021, 75, 514-517.

Kong X.D., Moriya J., Carle V., Pojer F., Abriata L.A., Deyle K., Heinis C. De novo development of proteolytically resistant therapeutic peptides for oral administration. Nat. Biomed. Eng., 2020, 4, 560–571.

Kong X.D., Carle V., Díaz-Perlas C., Butler K., Heinis C. Generation of a large peptide phage display library by self-ligation of whole-plasmid PCR product. ACS Chem. Biol., 2020, 15, 2907–2915.

Kale S.S.*, Villequey C.*, Kong X.D.*, Zorzi A., Deyle K., Heinis C. Cyclization of peptides with two chemical bridges affords large scaffold diversities. Nat. Chem., 2018, 10, 715-723.

Kong, X.D., Yuan, S.G., Li, L., Chen, S., Xu, J.H. and Zhou, J. Engineering of an epoxide hydrolase for efficient bioresolution of bulky pharmaco substrates. Proc. Natl. Acad. Sci. USA, 2014, 111, 15717-15722.